selected publications abstract Src Inhibition Through a Phase II Study of 5-Fluorouracil, Oxaliplatin, Plus Dasatinib (Folfox-D) in First-Line Metastatic Pancreatic Adenocarcinoma. Journal of Clinical Oncology. 2014-01-01